OBJECTIVES In this study, a systematic analysis was conducted of phasic intracoronary pressure and flow velocity in patients with severe aortic stenosis (AS) and coronary artery disease, undergoing transcatheter aortic valve replacement (TAVR), to determine how AS affects: 1) phasic coronary flow; 2) hyperemic coronary flow; and 3) the most common clinically used indices of coronary stenosis severity, instantaneous wave-free ratio and fractional flow reserve.
To validate whether an invasive index is accurate in determining lesion significance, in patients with severe AS, an understanding of how AS affects coronary flow is required. Transcatheter aortic valve replacement (TAVR) permits unique insights into the acute effects of AS on coronary physiology (7) because intracoronary physiology assessment can be made immediately before and after valve insertion, thereby minimizing any potential confounding factors. In this study, we aimed to use the TAVR model to determine how AS affects 1) phasic coronary flow; 2) hyperemic coronary flow; and 3) the most common clinically used indices of coronary stenosis severity, iFR and FFR.
METHODS
PATIENT POPULATION. Twenty-eight consecutive patients (30 lesions) with severe AS planned for TAVR and moderate to severe CAD were included. Recruiting centers were the Hammersmith Hospital, Imperial
College NHS Trust (London, United Kingdom) and Skane University Hospital (Lund, Sweden). TAVR was indicated by international guidelines (3) , and the treatment decision was made at a heart team meeting. Exclusion criteria were known nonviable myocardium in the area of the corresponding coronary artery being studied, contraindication to the administration of adenosine, inability to consent, and weight more than 200 kg. All participants gave written informed consent, and the study was given full ethical approval (14/SC/1103).
CARDIAC CATHETERIZATION PROTOCOL. Cardiac catheterization and coronary angiography were undertaken via either the transradial or transfemoral route at the operator's discretion, using standard equipment. A guiding catheter was used to intubate the vessel of interest. Heparin (5,000 U) was administered intra-arterially. A dual-pressure and Doppler sensor-equipped 0.014-inch guidewire was used for all physiological assessments (ComboWire, Volcano, San Diego, California). The guidewire signal was normalized in the aorta and then advanced a minimum of 3 vessel diameters distal to the stenosed segment. After an optimal and stable flow velocity signal was obtained, resting pressure and flow measurements were recorded. Hyperemia was then induced using a 150-mg bolus of intracoronary adenosine, and hyperemic measurements were made.
At the end of each recording, the pressure sensor was Coronary flow velocity (centimeters per second) was measured at baseline and during hyperemia.
Definitions of hemodynamic variables were as follows:
iFR ¼ Pd wfp /Pa wfp (6) Flow during the wave-free period of diastole
Hyperemic microvascular resistance (MVR)
Hyperemic stenosis resistance ¼ DP h /v h (11) where Pa is mean aortic pressure; Pd is mean intracoronary pressure distal to a stenosis; wfp is the wave-free period of diastole; v h is mean flow velocity distal to a stenosis during hyperemia; v b is mean flow velocity distal to a stenosis at baseline; DP h is Pa À Pd during hyperemia; and DP b is Pa À Pd at baseline.
Phasic analysis was performed to identify pressure and flow characteristics during different periods of the cardiac cycle. The wave-free period was identified using wave-intensity analysis as previously described (12) . A custom-written MATLAB algorithm was used to separate systole, diastole, and the wave-free period to facilitate phasic analysis of hemodynamic data. A schematic outlining how this was performed is shown in Figure 2 . Table 3 ).
Following TAVR, 15 patients (53.6%) had no paravalvular leak, 13 patients (46.4%) had trivial to mild paravalvular leak, and no patients had mild to moderate, moderate, or severe paravalvular leak ( Table 3) .
CORONARY FLOW PRE-AND
POST-TAVR. A summary of coronary hemodynamic parameters preand post-TAVR, under resting conditions and during hyperemia, is shown in Table 4 . An example of Ahmad et al.
invasive Doppler flow and pressure traces is shown in Previous coronary artery bypass grafting 1 (3.6) Values are mean AE SD or n (%). Values are mean AE SD or n (%).
LV ¼ left ventricular; TAVR ¼ transcatheter aortic valve replacement. Table 5 . The large diamonds denote the mean values, with the error bars denoting the upper and lower 95% confidence intervals.
Ahmad et al. 19) . This significant systolic increment in flow post-TAVR occurs at rest and during hyperemia ( Figure 6 ). Although these are both pressure-derived indices of Ahmad et al. coronary flow seen in our study, both at rest and during Hyperemia. The bars denote mean values, with the error bars denoting SEs.
Coronary Flow in Severe AS and CAD attenuated hyperemia in these patients, due to a blunted effect of adenosine resulting in failure to augment flow sufficiently to produce FFR values similar to those in patients without severe AS.
There is a paucity of available data regarding coronary stenosis assessment in patients with severe AS. Existing studies have not measured coronary flow and assumed that it is not affected by STUDY LIMITATIONS. This study included patients with severe symptomatic AS for whom TAVR was decreed the most appropriate therapy by the heart team, in accordance with international guidelines (3).
Our results cannot therefore be generalized to patients with more mild degrees of AS.
Adenosine was administered as an intracoronary bolus and not via intravenous infusion. We cannot therefore exclude the possibility that intravenous adenosine infusion would yield different results.
However, intracoronary adenosine is recognized as a valid approach to FFR assessment (31, 32) , and such assessments have been included in all the large randomized trials of physiology to date (33, 34) .
Intravenous infusion was avoided because of the recognized potential for a 15% reduction in aortic pressure (35) that could potentially destabilize a patient with severe AS.
Post-TAVR physiological measurements were made immediately after the valve had been replaced and within the same catheter laboratory procedure.
We cannot therefore comment on any more long-term changes in coronary hemodynamics.
The prevalence of severe aortic regurgitation has been significantly reduced with the development of the current generation of TAVR valves (36) . This is reflected in the presence of only trivial to mild aortic regurgitation in our dataset compared with other groups that used earlier generation valves (37, 38) . It is therefore unlikely that the degree of AR, which was mild at most in a minority of our patients, would explain the large differences seen in this study between systolic and diastolic parameters and hyperemia and resting parameters.
The sample size of our study may be considered small, with 30 coronary lesions across 28 patients.
However, this is the largest study to date of invasive coronary flow in patients with severe AS and the first to study patients with stenosed coronary arteries. It is also the first study to include phasic analysis, permitting an increase in our understanding of the coronary physiology in this complex he- 
